121 related articles for article (PubMed ID: 18756070)
1. Hypofractionated high-dose intensity-modulated radiotherapy (60 Gy at 2.5 Gy per fraction) for recurrent renal cell carcinoma: a case report.
Cho J; Kim GE; Rha KH; Ahn JB; Lee CG; Suh CO; Seong J; Keum KC; Kim SIe; Lee YH
J Korean Med Sci; 2008 Aug; 23(4):740-3. PubMed ID: 18756070
[TBL] [Abstract][Full Text] [Related]
2. [The intraoperative radiotherapy (IORT) of locally spread and recurrent renal-cell carcinomas].
Eble MJ; Staehler G; Wannenmacher M
Strahlenther Onkol; 1998 Jan; 174(1):30-6. PubMed ID: 9463562
[TBL] [Abstract][Full Text] [Related]
3. Hypofractionated postoperative irradiation in localized renal cell cancer: A case report and pertinent literature review.
Zhao XR; Shan GL; Zhang Y; Yu YH
J Cancer Res Ther; 2018; 14(Supplement):S260-S262. PubMed ID: 29578185
[TBL] [Abstract][Full Text] [Related]
4. Definitive radiotherapy in lieu of systemic therapy for oligometastatic renal cell carcinoma: a single-arm, single-centre, feasibility, phase 2 trial.
Tang C; Msaouel P; Hara K; Choi H; Le V; Shah AY; Wang J; Jonasch E; Choi S; Nguyen QN; Das P; Prajapati S; Yu Z; Khan K; Powell S; Murthy R; Sircar K; Tannir NM
Lancet Oncol; 2021 Dec; 22(12):1732-1739. PubMed ID: 34717797
[TBL] [Abstract][Full Text] [Related]
5. Tumor control outcomes after hypofractionated and single-dose stereotactic image-guided intensity-modulated radiotherapy for extracranial metastases from renal cell carcinoma.
Zelefsky MJ; Greco C; Motzer R; Magsanoc JM; Pei X; Lovelock M; Mechalakos J; Zatcky J; Fuks Z; Yamada Y
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1744-8. PubMed ID: 21596489
[TBL] [Abstract][Full Text] [Related]
6. Hypofractionated radiotherapy with concomitant sunitinib - is there a radiosensitizing effect?
Taussky D; Soulières D
Can J Urol; 2009 Apr; 16(2):4599-600. PubMed ID: 19364436
[TBL] [Abstract][Full Text] [Related]
7. Effect of Temporal Pattern of Radiation in Intensity Modulated Radiotherapy on Cell Cycle Progression and Apoptosis of ACHN Renal Cell Carcinoma Cell Line.
Khorramizadeh M; Saberi A; Tahmasebi-Birgani M; Shokrani P; Amouhedari A
Pak J Biol Sci; 2016; 19(8-9):315-322. PubMed ID: 29023017
[TBL] [Abstract][Full Text] [Related]
8. Outcomes in a multi-institutional cohort of patients treated with intraoperative radiation therapy for advanced or recurrent renal cell carcinoma.
Paly JJ; Hallemeier CL; Biggs PJ; Niemierko A; Roeder F; Martínez-Monge R; Whitson J; Calvo FA; Fastner G; Sedlmayer F; Wong WW; Ellis RJ; Haddock MG; Choo R; Shipley WU; Zietman AL; Efstathiou JA
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):618-23. PubMed ID: 24411190
[TBL] [Abstract][Full Text] [Related]
9. Hyperfractionation compared to standard fractionation in intensity-modulated radiation therapy for patients with locally advanced recurrent nasopharyngeal carcinoma.
Lee VH; Kwong DL; Leung TW; Ng SC; Lam KO; Tong CC; Sze CK
Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):1067-1078. PubMed ID: 27738820
[TBL] [Abstract][Full Text] [Related]
10. [Intraoperative electron irradiation (IORT) of urologic tumors. Initial results of a pilot study of local recurrences of renal cell cancers].
Beer M; Eble MJ; Wannenmacher M; Staehler G
Urologe A; 1994 Mar; 33(2):110-5. PubMed ID: 8178404
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcomes after maximal surgical resection and intraoperative electron radiotherapy for locoregionally recurrent or locoregionally advanced primary renal cell carcinoma.
Hallemeier CL; Choo R; Davis BJ; Pisansky TM; Gunderson LL; Leibovich BC; Haddock MG
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1938-43. PubMed ID: 21514065
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic ablative radiation therapy for oligometastatic renal cell carcinoma (SABR ORCA): a meta-analysis of 28 studies.
Zaorsky NG; Lehrer EJ; Kothari G; Louie AV; Siva S
Eur Urol Oncol; 2019 Sep; 2(5):515-523. PubMed ID: 31302061
[TBL] [Abstract][Full Text] [Related]
13. [Not Available].
Mery B; Rancoule C; Rowinski E; Bosacki C; Vallard A; Guy JB; Magné N
Bull Cancer; 2018 Dec; 105 Suppl 3():S280-S285. PubMed ID: 30595157
[TBL] [Abstract][Full Text] [Related]
14. A phase II study of palliative radiotherapy combined with zoledronic acid hydrate for metastatic bone tumour from renal cell carcinoma.
Harada H; Shikama N; Wada H; Uchida N; Nozaki M; Hayakawa K; Yamada K; Nagakura H; Ogawa H; Miyazawa K; Katagiri H; Nakamura N
Jpn J Clin Oncol; 2021 Jan; 51(1):100-105. PubMed ID: 32869095
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous Integrated Boost for Radiation Dose Escalation to the Gross Tumor Volume With Intensity Modulated (Photon) Radiation Therapy or Intensity Modulated Proton Therapy and Concurrent Chemotherapy for Stage II to III Non-Small Cell Lung Cancer: A Phase 1 Study.
Jeter MD; Gomez D; Nguyen QN; Komaki R; Zhang X; Zhu X; O'Reilly M; Fossella FV; Xu T; Wei X; Wang H; Yang W; Tsao A; Mohan R; Liao Z
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):730-737. PubMed ID: 29248169
[TBL] [Abstract][Full Text] [Related]
16. Intensity-modulated stereotactic radiotherapy of paraspinal tumors: a preliminary report.
Bilsky MH; Yamada Y; Yenice KM; Lovelock M; Hunt M; Gutin PH; Leibel SA
Neurosurgery; 2004 Apr; 54(4):823-30; discussion 830-1. PubMed ID: 15046647
[TBL] [Abstract][Full Text] [Related]
17. Local control rates of metastatic renal cell carcinoma (RCC) to the bone using stereotactic body radiation therapy: Is RCC truly radioresistant?
Amini A; Altoos B; Bourlon MT; Bedrick E; Bhatia S; Kessler ER; Flaig TW; Fisher CM; Kavanagh BD; Lam ET; Karam SD
Pract Radiat Oncol; 2015; 5(6):e589-e596. PubMed ID: 26142027
[TBL] [Abstract][Full Text] [Related]
18. Carbon ion radiation therapy for primary renal cell carcinoma: initial clinical experience.
Nomiya T; Tsuji H; Hirasawa N; Kato H; Kamada T; Mizoe J; Kishi H; Kamura K; Wada H; Nemoto K; Tsujii H
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):828-33. PubMed ID: 18374507
[TBL] [Abstract][Full Text] [Related]
19. Intensity-modulated radiation therapy in the salvage of locally recurrent nasopharyngeal carcinoma.
Qiu S; Lin S; Tham IW; Pan J; Lu J; Lu JJ
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):676-83. PubMed ID: 22024207
[TBL] [Abstract][Full Text] [Related]
20. Durable Response to Treatment With Combination Radiotherapy and High-dose Interleukin-2 in Metastatic Chromophobe Variant Renal Cell Carcinoma.
Merriman J; Tward J; Albertson D; Dechet C; Agarwal N
J Immunother; 2016; 39(2):101-3. PubMed ID: 26849079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
